Skip to content

EFFECT ON QUALITY OF LIFE AFTER PROSTATECTOMY

THE EFFECT OF PELVIC FLOOR EXERCISES ON URINARY INCONTINENCE AND QUALITY OF LIFE AFTER PROSTATECTOMY

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05700487
Enrollment
33
Registered
2023-01-26
Start date
2019-08-01
Completion date
2021-04-29
Last updated
2023-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PROSTATECTOMY, URINARY INCONTINENCE

Keywords

Radical Prostatectomy, Pelvic Floor Exercises, Urinary Incontinence, Quality of life

Brief summary

Aim: This study was conducted to determine the effect of pelvic floor exercises (PTE) on urinary incontinence and quality of life (QOL) after radical prostatectomy (RP). Methods: This randomized controlled, single-blind, experimental study was completed with a total of 33 RP patients, 18 of whom were interventions, and 15 were controls. The intervention group was given pelvic floor exercises (PTE) training in the preoperative period, regular PTE was performed three times a day for six months in the postoperative period, and the continuity of the exercises was checked by telephone. On the other hand, no intervention was applied to the control group other than routine treatment.

Interventions

Regular Pelvic floor exercises was performed three times a day for six months in the postoperative period

Sponsors

TC Erciyes University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Masking description

The person applying the data sheets is an unbiased surveyor who does not know about the groups.

Eligibility

Sex/Gender
MALE
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Being literate, * Having the mental competence to understand the questions, * Radical prostatectomy was performed due to the diagnosis of localized prostate cancer, * Continuing post-operative follow-up, * No incontinence problem before surgery, * Anatomically free of genito-urinary system pathology, * Those who volunteered to participate in the study were recruited.

Exclusion criteria

\- With bladder insufficiency (dysfunction), • Individuals with a different type of incontinence problem such as stress incontinence, neurogenic bladder were not included in the study.

Design outcomes

Primary

MeasureTime frameDescription
Quality of life Scale(SF-36)The first measurement was made when the patients were included in the study.It measures the quality of life of individuals in 7 dimensions. These dimensions are physical function, social function, role limitations due to physical functions, role limitations due to emotional problems, mental health energy/vitality, pain and general perception of health. Instead of giving only a single total score, the scale is for each subscale. gives a total score separately. Subscales evaluate health from 0 to 100. 0 points denotes the worst health condition, and 100 points denotes the best health condition.

Secondary

MeasureTime frameDescription
The Overactive Bladder (OAB-V8 )The first measurement was made when the patients were included in the study.Used to determine clinical incontinence. The OAB- V8 inquiry form determined the severity of the patients' complaints, none (0); very few (1); a little (2); quite a few (3); many (4); and it consists of 8 questions that can be graded as too many (5). The total score ranges from 0 to 40.

Other

MeasureTime frameDescription
The Marmara Post-Prostatectomy Incontinence Symptom Score FormThe first measurement was made when the patients were included in the study.It determines how incontinence affects an individual's life. The survey consists of 8 questions and 3 parts. Point values between 0 and 28 can be obtained from the questionnaire. A high total score indicates an increase in the negative impact of incontinence on the patient.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026